| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/06/1996 | US5489668 Immunoassay reagents and method for determining cyclosporine |
| 02/06/1996 | US5489528 Recombinant core-streptavidin |
| 02/06/1996 | US5489527 Translation of m-RNA |
| 02/06/1996 | US5489525 Monoclonal antibodies to prostate cells |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489432 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 02/06/1996 | CA2155451A1 Dna sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 02/06/1996 | CA2056437C Production of virus and purification of viral envelope proteins for vaccine use |
| 02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/01/1996 | WO1996002661A1 Process for producing protein capable of molecular weight reduction caused by protease of host-cell origin |
| 02/01/1996 | WO1996002660A1 Positional control of selenium insertion in polypeptides for x-ray crystallography |
| 02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 02/01/1996 | WO1996002640A1 Alpha-lactalbumin gene constructs |
| 02/01/1996 | WO1996002638A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 02/01/1996 | WO1996002636A1 Genes encoding and method of expressing a novel enzyme: phthalyl amidase |
| 02/01/1996 | WO1996002634A1 Active calpain expressed by baculovirus |
| 02/01/1996 | WO1996002576A1 Reconstituted human antibody against human interleukin-8 |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002567A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | WO1996002562A1 Process for the purification of basic fibroblast growth factor |
| 02/01/1996 | WO1996002561A1 Interaction trap systems for detecting protein interactions |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | WO1995034668A3 The cytoplasmic inhibition of gene expression |
| 02/01/1996 | WO1995034655A3 Surface protein of staphylococcus aureus |
| 02/01/1996 | CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof |
| 02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194907A1 Reshaped human antibody against human interleukin-8 |
| 02/01/1996 | CA2194861A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | CA2194783A1 Genes encoding and method of expressing a novel enzyme: phthalyl amidase |
| 02/01/1996 | CA2194763A1 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 02/01/1996 | CA2193513A1 Alpha-lactalbumin gene constructs |
| 02/01/1996 | CA2192681A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 01/31/1996 | EP0694560A2 Production of antigens of Pasteurella |
| 01/31/1996 | EP0694309A2 Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection |
| 01/31/1996 | EP0694075A1 Thermostable dna topoisomerase v |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694069A1 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
| 01/31/1996 | EP0694068A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 01/31/1996 | EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 01/31/1996 | EP0694062A1 New bacillus thuringiensis strains and their insecticidal proteins |
| 01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0538352B1 IMMUNOGENIC PEPTIDE SEQUENCE FROM $i(ECHINOCOCCUS GRANULOSUS), DNA SEQUENCE CODING FOR SAID PEPTIDE SEQUENCE, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 01/31/1996 | EP0502928B1 Methods of detecting bone resorption in vivo |
| 01/31/1996 | EP0455785B1 Leucocyte elastasis and cathepsin g-blocking peptide |
| 01/30/1996 | US5488099 Multifunctional chimeric neurotrophic factors |
| 01/30/1996 | US5487991 Polypeptides and dna sequences for plants and proteins |
| 01/30/1996 | US5487984 Processes for producing tumor necrosis factor |
| 01/30/1996 | US5487983 Expression systems for making single-chain monellin analogs |
| 01/30/1996 | US5487980 Improved method for producing polypeptides by bacterial fermentation |
| 01/30/1996 | US5487977 Using a single immunoenzymatic elisa assay based on the interaction between one and several monoclonal anti-sulfidoleukotriene antibodies and a sulfidoleukotriene conjugated to a revealing enzyme |
| 01/30/1996 | US5487892 Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| 01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
| 01/30/1996 | CA1338011C Oncostatin m and novel compositions having anti-neoplastic activity |
| 01/30/1996 | CA1338010C Heat shock promoter and gene |
| 01/25/1996 | WO1996002004A1 Immunoassay for mycophenolic acid |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001906A1 Kinetically controlled process for enzymatic production of peptides |
| 01/25/1996 | WO1996001901A1 Streptogramines and method for preparing same by mutasynthesis |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/25/1996 | WO1996001846A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001839A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 01/25/1996 | WO1995032292A3 Detection of viral antigens coded by reverse-reading frames |
| 01/25/1996 | CA2194548A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | CA2194439A1 Immunoassay for mycophenolic acid |
| 01/25/1996 | CA2194299A1 Novel cytokine designated lerk-5 |
| 01/24/1996 | EP0693687A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693132A1 Rapamycin assay |
| 01/24/1996 | EP0693131A1 Cell free system for protein synthesis and use of chaperone proteins therein |
| 01/24/1996 | EP0693124A1 Human osteoclast-specific and -related genes |
| 01/24/1996 | EP0693122A1 Glutamylcysteine synthetase light subunit |
| 01/24/1996 | EP0693121A1 Monoclonal antibody 88bv59, subclones and method of making |
| 01/24/1996 | EP0693085A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
| 01/24/1996 | EP0693084A1 Chimeric cytokine receptors in lymphocytes |
| 01/24/1996 | EP0693078A1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0631617A4 Colon crypt cell mitogen, cell line producing it, and uses thereof. |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/24/1996 | EP0440619B1 Antibody to a4 amyloid peptide |
| 01/23/1996 | US5486472 Polypeptides |